Biogen
Health
FDA Approves the Leqembi Drug that Slows Alzheimer’s Progress
The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen and Eisai Alzheimer’s treatment Leqembi.
Leqembi, also known as lecanemab, is the first drug shown to slow the progress of the disease, rather than just treating...
Greek News
The Greek Doctor Behind the New Alzheimer’s Drug
A Greek, born and bred in Thessaloniki, is offering the world a wonder drug. No, his name is not Albert Bourla of Pfizer. Stelios Papadopoulos of Biogen will help millions with Alzheimer's.
Health
New Alzheimer’s Drug Designed to Slow Disease Approved by FDA
The FDA has approved a new drug shown to slow down the early stages of Alzheimer’s despite controversy surrounding some of its more serious side effects.
Lecanemab, the first drug to actively decelerate the progress of the disease, seems to...
Diaspora
New Alzheimer’s Drug Developed By Greek Scientists
Aduhelm, a new, completely revolutionary treatment for the dreaded disease of Alzheimer's was approved on Wednesday by the FDA.